<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00306280</url>
  </required_header>
  <id_info>
    <org_study_id>lmrx01</org_study_id>
    <nct_id>NCT00306280</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Phototherapy System to Treat H Pylori</brief_title>
  <official_title>Phase 1 Study of Phototherapy System to Treat H Pylori</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LumeRx</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LumeRx</source>
  <brief_summary>
    <textblock>
      This purpose of this study is to determine whether phototherapy can be used to safely and
      effectively treat H pylori.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      H pylori causes almost all peptic ulcers and many gastric cancers and is widely prevalent
      worldwide. Treatment by multiple antibiotics and proton pump inhibitors is effective but are
      compromised today by significant non compliance due to side effects and duration of required
      treatment. Also, the increase in antibiotic resistance coupled with the decreased
      availability of new antibiotics project a significant population of patients who will not be
      treatable with antibiotics.

      A special, visible-light based phototherapy system has been demonstrated to significantly
      decrease the viability of H pylori in vitro and in a brief clinical experiment.

      This study will evaluate the safety and short term efficacy in up to 60 patients of the
      phototherapy system to treat H pylori.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <completion_date>March 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Negative urease breath test at five weeks post procedure</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural Side Effects</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative urease breath test at 5 days post procedure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in acute post treatment bacterial population with respect to pretreatment samples</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Helicobacter Pylori</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 and &lt; 90

          -  Documented positive for H. pylori infection by urease breath test, stool antigen or
             histology within thirty days prior to procedure

          -  Willing to comply with study requirements

          -  Able to undergo endoscopic esophagogastroduodenoscopy (EGD) with biopsy

        Exclusion Criteria:

          -  History of gastric or duodenal carcinoma

          -  History of prior gastric or duodenal surgery

          -  Oral or intravenous antibiotics use within previous one month

          -  Use of bismuth subsalicylate (Pepto Bismol) within previous one month

          -  Use of photosensitizing drugs or nutritional supplements within previous one month

          -  Active peptic ulcer disease (gastric or duodenal ulcer)

          -  Esophagitis Grade II or higher

          -  Oral or intravenous antibiotics use within previous one month

          -  History of a bleeding disorder or anti-coagulant use that would prevent biopsy

          -  PPI treatment two weeks prior to the scheduled endoscopy

          -  Positive Pregnancy Test

          -  Known porphyria

          -  Suffer from phenylketonuria (PKU)

          -  Signs of jaundice

          -  Weight &lt; 100 lb or &gt; 250 lb

          -  Previously enrolled in this study

          -  Participating in another ongoing clinical trial in which concomitant diagnosis or
             therapeutic intervention would adversely affect the integrity of this study

          -  The subject is inappropriate for study participation, as determined by the
             Investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beth Israel Deaconness Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Lembo, MD</last_name>
      <phone>617-667-2138</phone>
      <email>alembo@bidmc.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Eoin Kelly, BS</last_name>
      <phone>(617) 632 1108</phone>
      <email>eckelly@bidmc.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Anthony Lembo</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sinil Sheth</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Cave</last_name>
      <phone>508-856-8399</phone>
      <email>drcave@pol.net</email>
    </contact>
    <contact_backup>
      <last_name>Ann Foley</last_name>
      <phone>(508) 334-4098</phone>
      <email>foleya@ummhc.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Cave</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55430</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Ganz, MD</last_name>
      <phone>612-871-1145</phone>
      <phone_ext>82941</phone_ext>
      <email>gastrodude@visi.com</email>
    </contact>
    <contact_backup>
      <last_name>Anne Hopper, BS</last_name>
      <phone>(612) 870 5594</phone>
      <email>ahopper@mngastro.com</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Ganz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2006</study_first_submitted>
  <study_first_submitted_qc>March 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2006</study_first_posted>
  <last_update_submitted>September 19, 2006</last_update_submitted>
  <last_update_submitted_qc>September 19, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2006</last_update_posted>
  <keyword>Helicobacter pylori</keyword>
  <keyword>phototherapy</keyword>
  <keyword>peptic ulcer</keyword>
  <keyword>gastric cancer</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

